BACKGROUND: The presence of pathological Q waves in the infarct leads on the surface electrocardiogram in an ST-elevation acute myocardial infarction indicates myocardial necrosis. Clinically it might be difficult to ascertain the onset of acute myocardial infarction. Our aim was to assess whether the presence or absence of Q waves at presentation could be used as an indicator of the duration of acute myocardial infarction and predict mortality. METHODS:15,222 patients with ST-elevation acute myocardial infarction and normal intraventricular conduction were randomly assigned streptokinase and aspirin plus bivalirudin or unfractionated heparin in the HERO-2 trial; randomisation did not alter 30-day mortality. 10,244 patients (67%) had Q waves in the infarct territory at the time of randomisation, and 4978 (33%) did not. The primary endpoint was 30-day mortality. FINDINGS: There were more deaths at 30 days in patients with initial Q waves than in those without (1044 [10%] vs 344 [7%], p<0.0001). These findings were similar in patients with a first acute myocardial infarction and when stratified by time to randomisation (0-2, >2-4, >4 h) and by acute myocardial infarction location (anterior or inferior). Both the presence of initial Q waves and time to randomisation were positive univariate predictors, but only the presence of initial Q waves independently predicted 30-day mortality on multivariate analysis (adjusted OR 1.44, 95% CI 1.25-1.65 with clinical indices, and 1.31, 1.12-1.54 with clinical plus ST indices included as predictors). INTERPRETATION: The presence of Q waves in the infarct leads at presentation of ST-elevation acute myocardial infarction independently predicts higher 30-day mortality in patients treated with fibrinolytic therapy. Therefore, a more aggressive approach to reperfusion might be warranted in these patients.
RCT Entities:
BACKGROUND: The presence of pathological Q waves in the infarct leads on the surface electrocardiogram in an ST-elevation acute myocardial infarction indicates myocardial necrosis. Clinically it might be difficult to ascertain the onset of acute myocardial infarction. Our aim was to assess whether the presence or absence of Q waves at presentation could be used as an indicator of the duration of acute myocardial infarction and predict mortality. METHODS: 15,222 patients with ST-elevation acute myocardial infarction and normal intraventricular conduction were randomly assigned streptokinase and aspirin plus bivalirudin or unfractionated heparin in the HERO-2 trial; randomisation did not alter 30-day mortality. 10,244 patients (67%) had Q waves in the infarct territory at the time of randomisation, and 4978 (33%) did not. The primary endpoint was 30-day mortality. FINDINGS: There were more deaths at 30 days in patients with initial Q waves than in those without (1044 [10%] vs 344 [7%], p<0.0001). These findings were similar in patients with a first acute myocardial infarction and when stratified by time to randomisation (0-2, >2-4, >4 h) and by acute myocardial infarction location (anterior or inferior). Both the presence of initial Q waves and time to randomisation were positive univariate predictors, but only the presence of initial Q waves independently predicted 30-day mortality on multivariate analysis (adjusted OR 1.44, 95% CI 1.25-1.65 with clinical indices, and 1.31, 1.12-1.54 with clinical plus ST indices included as predictors). INTERPRETATION: The presence of Q waves in the infarct leads at presentation of ST-elevation acute myocardial infarction independently predicts higher 30-day mortality in patients treated with fibrinolytic therapy. Therefore, a more aggressive approach to reperfusion might be warranted in these patients.
Authors: Kimmo Koivula; Kjell Nikus; Juho Viikilä; Jyrki Lilleberg; Heini Huhtala; Yochai Birnbaum; Markku Eskola Journal: Ann Noninvasive Electrocardiol Date: 2018-09-06 Impact factor: 1.468
Authors: Ioanna Kosmidou; Björn Redfors; Aaron Crowley; Bernard Gersh; Shmuel Chen; José M Dizon; Monica Embacher; Roxana Mehran; Ori Ben-Yehuda; Gary S Mintz; Gregg W Stone Journal: Clin Cardiol Date: 2017-07-11 Impact factor: 2.882
Authors: Hany Siha; Debraj Das; Yuling Fu; Yinggan Zheng; Cynthia M Westerhout; Robert F Storey; Stefan James; Lars Wallentin; Paul W Armstrong Journal: CMAJ Date: 2012-04-30 Impact factor: 8.262
Authors: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Jocelyne Benatar; John K French; Philip E G Aylward; Harvey D White Journal: Eur Heart J Date: 2010-05-31 Impact factor: 29.983
Authors: Harvey D White; Cheuk-Kit Wong; Wanzhen Gao; Aaron Lin; Jocelyne Benatar; Philip Eg Aylward; John K French; Ralph A Stewart Journal: Eur Heart J Acute Cardiovasc Care Date: 2012-09
Authors: Marta López-Castillo; Álvaro Aceña; Ana M Pello-Lázaro; Vanessa Viegas; Beatriz Merchán Muñoz; Rocío Carda; Juan Franco-Peláez; Maria Luisa Martín-Mariscal; Sem Briongos-Figuero; Jose Tuñón Journal: Ann Noninvasive Electrocardiol Date: 2020-08-26 Impact factor: 1.468